About Teladoc Health, Inc.
https://www.teladochealth.comTeladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.
CEO
Charles Divita III, CPA
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 152
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Canaccord Genuity
Buy
Goldman Sachs
Buy
RBC Capital
Outperform
Oppenheimer
Outperform
Piper Sandler
Overweight
Wells Fargo
Equal Weight
Grade Summary
Showing Top 6 of 13
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:21.91M
Value:$144.83M
BLACKROCK INC.
Shares:21.61M
Value:$142.85M
BLACKROCK, INC.
Shares:13.88M
Value:$91.74M
Summary
Showing Top 3 of 504
About Teladoc Health, Inc.
https://www.teladochealth.comTeladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $626.44M ▼ | $491.22M ▼ | $-49.51M ▼ | -7.9% ▼ | $-0.28 ▼ | $-35.18M ▼ |
| Q2-2025 | $631.9M ▲ | $495.75M ▼ | $-32.66M ▲ | -5.17% ▲ | $-0.19 ▲ | $2.67M ▲ |
| Q1-2025 | $629.37M ▼ | $553.15M ▲ | $-93.01M ▼ | -14.78% ▼ | $-0.53 ▼ | $-8.96M ▼ |
| Q4-2024 | $640.49M ▼ | $499.78M ▼ | $-48.41M ▼ | -7.56% ▼ | $-0.28 ▼ | $11.78M ▼ |
| Q3-2024 | $640.51M | $505.16M | $-33.28M | -5.2% | $-0.2 | $13.39M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $726.25M ▲ | $2.88B ▼ | $1.49B ▲ | $1.39B ▼ |
| Q2-2025 | $679.62M ▼ | $2.89B ▼ | $1.47B ▼ | $1.42B ▼ |
| Q1-2025 | $1.19B ▼ | $3.44B ▼ | $2.02B ▼ | $1.43B ▼ |
| Q4-2024 | $1.3B ▲ | $3.52B ▼ | $2.03B ▲ | $1.49B ▼ |
| Q3-2024 | $1.24B | $3.53B | $2.02B | $1.51B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-49.51M ▼ | $99.26M ▲ | $-48.72M ▲ | $-3.59M ▲ | $46.63M ▲ | $67.95M ▼ |
| Q2-2025 | $-32.66M ▲ | $91.43M ▲ | $-59.7M ▲ | $-549.93M ▼ | $-513.71M ▼ | $90.16M ▲ |
| Q1-2025 | $-93.01M ▼ | $15.92M ▼ | $-123.27M ▼ | $769K ▼ | $-105M ▼ | $-15.67M ▼ |
| Q4-2024 | $-48.41M ▼ | $85.9M ▼ | $-29.64M ▲ | $2.06M ▲ | $54.46M ▼ | $56.26M ▼ |
| Q3-2024 | $-33.28M | $110.17M | $-31.15M | $698K | $81.48M | $79.03M |
Revenue by Products
| Product | Q3-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Other | $90.00M ▲ | $100.00M ▲ | $110.00M ▲ | $110.00M ▲ |
Revenue by Geography
| Region | Q4-2024 | Q3-2025 | Q2-2025 | Q1-2025 |
|---|---|---|---|---|
 NonUS | $110.00M ▲ | $120.00M ▲ | $110.00M ▼ | $100.00M ▼ |
 UNITED STATES | $540.00M ▲ | $510.00M ▼ | $520.00M ▲ | $520.00M ▲ |
CEO
Charles Divita III, CPA
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 152
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Canaccord Genuity
Buy
Goldman Sachs
Buy
RBC Capital
Outperform
Oppenheimer
Outperform
Piper Sandler
Overweight
Wells Fargo
Equal Weight
Grade Summary
Showing Top 6 of 13
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:21.91M
Value:$144.83M
BLACKROCK INC.
Shares:21.61M
Value:$142.85M
BLACKROCK, INC.
Shares:13.88M
Value:$91.74M
Summary
Showing Top 3 of 504